Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1990-07-06
1992-04-07
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
560 1, 560 39, 560 31, 560 32, 560 42, 560 45, 560 47, 560 56, 560 49, 560 61, 560 63, 560 29, 560 30, 560123, 560121, 560124, 560126, 560125, 560157, 560160, 560161, 560162, 560183, 560184, 560188, 560119, 560256, 546205, 546206, 544387, 548531, 548532, 558428, 519480, 519482, 519824, 519460, 549292, 514255, 514423, 514319, A61K 31215, C07C 69608
Patent
active
051029111
ABSTRACT:
HMG-CoA reductase inhibitors of formulae (I) and (II) are disclosed. ##STR1##
REFERENCES:
patent: 4448979 (1984-05-01), Terahara et al.
patent: 4533859 (1985-08-01), Terahara et al.
patent: 4604472 (1986-08-01), Ide et al.
patent: 4611068 (1986-09-01), Guirdon
patent: 4733003 (1988-03-01), Ide et al.
patent: 4766145 (1988-08-01), Lee et al.
patent: 4855456 (1989-08-01), Lee et al.
patent: 4866090 (1989-09-01), Hoffman et al.
Holtz Wilbur J.
Lee Ta J.
DiPrima Joseph F.
Hollrah Glennon H.
Merck & Co Inc.
Russell Mark W.
Winokur Melvin
LandOfFree
4-Substituted HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-Substituted HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-Substituted HMG-CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1895735